Table 1 patients from high volume centers (HCV) main characteristics
Global HVC | % | HVTCA | % | HVCCC | % | HVTCA versus HVCCC | |
|---|---|---|---|---|---|---|---|
Age | |||||||
< 60 | 15 | 21.0 | 11 | 23.5 | 4 | 19.0 | P = 0.81 |
≥ 60 | 57 | 79.0 | 36 | 76.5 | 21 | 81.0 | |
Sex | |||||||
M | 43 | 59.7 | 24 | 51.0 | 19 | 76.0 | P = 0.62 |
F | 29 | 40.3 | 23 | 49.0 | 6 | 24.0 | |
Primary/recurrent | |||||||
Primary | 46 | 63.8 | 32 | 68.0 | 14 | 56.0 | P = 0.30 |
Recurrent | 26 | 36.2 | 15 | 32.0 | 11 | 44.0 | |
Diameter | |||||||
< 10 cm | 22 | 30.5 | 15 | 32.0 | 7 | 28.0 | P = 0.26 |
≥ 10 cm | 50 | 69.5 | 32 | 68.0 | 18 | 72.0 | |
Histotype | |||||||
Liposarcoma | 40 | 55.5 | 24 | 51.0 | 16 | 64.0 | P = ns |
Leiomyosarcoma | 10 | 14.0 | 9 | 19.0 | 1 | 4.0 | |
Sarcoma NOS | 8 | 11.0 | 1 | 2.0 | 7 | 28.0 | |
Others | 14 | 19.5 | 13 | 28.0 | 1 | 4.0 | |
Grading | |||||||
1 | 10 | 14.0 | 7 | 14.8 | 3 | 12.0 | P = 0.9 |
2 | 22 | 31.0 | 18 | 38.2 | 4 | 19.0 | |
3 | 27 | 37.5 | 14 | 30.0 | 13 | 52.0 | |
Unknown | 13 | 17.5 | 8 | 17.0 | 5 | 17.0 | |
Preoperative biopsy | |||||||
Yes | 46 | 63.8 | 31 | 66.5 | 15 | 60.0 | P = 0.45 |
No | 26 | 36.2 | 16 | 33.5 | 10 | 40.0 | |
Margins | |||||||
R0 | 20 | 28.0 | 10 | 21.0 | 10 | 40.0 | R0 + R1 versus R2 P = 0.013 |
R1 | 23 | 32.0 | 13 | 28.0 | 10 | 40.0 | |
R2 | 18 | 25.0 | 15 | 32.0 | 3 | 12.0 | |
Unknown | 11 | 15.0 | 9 | 19.0 | 2 | 8.0 | |
Fragmentation | |||||||
Yes | 36 | 50.0 | 30 | 63.8 | 6 | 24.0 | P = 0.01 |
No | 36 | 50.0 | 17 | 36.2 | 19 | 76.0 | |